Repository logo
  • English
  • Français
  • Log In
    New user? Click here to register.Have you forgotten your password?
Repository logo
  • Communities & Collections
  • Research Outputs
  • Fundings & Projects
  • People
  • Statistics
  • English
  • Français
  • Log In
    New user? Click here to register.Have you forgotten your password?
  1. Home
  2. Centre for Global Surgery
  3. Prof. Abebe Bekele
  4. Epidermal growth factor receptor (EGFR) and vascular endothelial growth factor A (VEGF-A) expressions in Ethiopian female breast cancer and their association with histopathologic features
 
  • Details
Options

Epidermal growth factor receptor (EGFR) and vascular endothelial growth factor A (VEGF-A) expressions in Ethiopian female breast cancer and their association with histopathologic features

Journal
PLOS ONE
ISSN
1932-6203
Date Issued
2024-10-15
Author(s)
Sisay Addisu
Abebe Bekele
Daniel Seifu
Mathewos Assefa
Tufa Gemechu
Mark J. Hoenerhoff
Sofia D. Merajver
Editor(s)
Daniele Ugo Tari
DOI
https://doi.org/10.1371/journal.pone.0308411
Abstract
<jats:sec id="sec001">
<jats:title>Background</jats:title>
<jats:p>Epidermal growth factor receptor (EGFR) and vascular endothelial growth factor receptor (VEGF) play important role in breast tumor growth, invasion, metastasis, patient survival and drug resistance. The aim of this study was to evaluate the protein expression status of EGFR and VEGF-A, as well as their association with hormone receptor status and histopathological characteristics in the invasive type of female breast cancer among Ethiopians.</jats:p>
</jats:sec>
<jats:sec id="sec002">
<jats:title>Method</jats:title>
<jats:p>The primary breast tumor tissues were obtained from 85 Ethiopian invasive breast cancer cases that underwent modified radical mastectomy (MRM) from June 2014 to June 2015. Their FFPE blocks were analyzed for EGFR and VEGF protein expressions using immunohistochemical techniques. The expressions were also correlated with histopathologic features.</jats:p>
</jats:sec>
<jats:sec id="sec003">
<jats:title>Result</jats:title>
<jats:p>Epidermal growth factor receptor over-expression was observed in 22% of the tumor samples. VEGF-A expression was negative in 13.41%, low in 63.41%, moderate in 20.73%, and high in 2.44%. EGFR expression, but not VEGF-A, showed a significant inverse correlation with both estrogen receptor (ER) (<jats:italic>P</jats:italic> = 0.01) and progesterone receptor (PR) statuses (<jats:italic>P</jats:italic> = 0.04). EGFR and VEGF expressions did not show significant association with tumor size, grade, lymph node status or age at diagnosis.</jats:p>
</jats:sec>
<jats:sec id="sec004">
<jats:title>Conclusion</jats:title>
<jats:p>Epidermal growth factor receptor expression was most likely associated with ER and PR negative tumors. Assessments of multiple molecular markers aid to understand the biological behavior of the disease in Ethiopian population. It might also help to predict which group of patients might get more benefit from the selected treatment strategies and which are not.</jats:p>
</jats:sec>
Subjects

Breast cancer

Ethiopia

Cancer treatment

Histology

File(s)
No Thumbnail Available
Name

journal.pone.0308411.pdf

Size

482.53 KB

Format

Adobe PDF

Checksum

(MD5):18d462346f473a08e5b103a2f06649eb

  • logo.footer.image.logo
  • grid-colum.footer.image.logo
Rwanda:

Office Hours: 8:00 a.m. - 5:00 p.m.
p: 0786.405.072
Kigali Heights, Plot 772
KG 7 Ave., 5th Floor
PO Box 6955
Kigali

United States:

Office Hours: 9:00 a.m. - 5:00 p.m.
800 Boylston Street, Suite 300
Boston, MA 02199

Connect with us:

View our privacy policy.

If you are interested in working for the university, please visit our job board for open positions.

To get in touch with UGHE, please send us an email.

Copyright © 2024, UGHE.org All Rights Reserved

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Cookie settings
  • Privacy policy
  • End User Agreement
  • Send Feedback